Investors may be closely watching the levels on shares of Flexion Therapeutics (FLXN). After a recent scan, we can see that last month’s opinion signal is 88% Sell. This is the combined signal for the previous month when applying a wide array of studies based on price movement. Using these same guidelines, the signal for last week stands at 8% Buy, and 24% Buy for the previous trading session. Investors may also be interested in the strength and direction of the opinion signals. The opinion direction is currently Average. This is a measurement over the past three trading sessions that provides an indication of whether the latest recent price movement is following the signal.

A Buy or Sell signal with a “Strongest” direction indicates that the signal is gaining strength. The opinion strength signal is presently reading Weak. This is a longer-term gauge verse the historical strength.

As we move closer to the end of the year, investors might be closely monitoring key economic reports. Staying on top of the most recent reports can help the individual see the overall landscape a bit clearer. It may be overwhelming to keep up with every single report that comes out, but knowing which information has a bigger impact on stock investments may help the investor. Investors may already be trying to gauge how they will set themselves up for success over the next couple of quarters. They may be still going over all the latest company earnings reports trying to identify some names that can give the portfolio a boost as we move into the New Year.

We are also noting that the company’s current book value is 1.09. The book value is the per share value of a company based on its equity available to common shareholders for the trailing 12 months. 

Shifting the gaze to some longer-term technical indicators, we can see that Flexion Therapeutics currently has a 60-day commodity channel index signal of Buy. The CCI indicator is typically used to scope out overbought and oversold levels. The 100-day moving average verse price signal is Buy.

Active investing may be highly stressful at times. Investors often set up trades with the best intentions, but have the tendency to let too much emotion seep into the situation. When dealing with the emotions of market stress, investors may need to figure out how to keep emotions in check in order to make the right decision. This may come easy to some but much harder for others. Because there is no one right way to trade, investors may have to experience certain scenarios for themselves. Creating a plan from the outset may help the investor when tough decisions need to be made. Keeping cool under pressure is a trait shared by many successful investors. When the investor is focused on a plan or specific trading system, this can make things a bit easier when times get tough.

Tracking current trading session activity on shares of Flexion Therapeutics (FLXN), we can see that the stock price recently hit 13.31. Since the start of the session, the stock has topped out with a high of 13.64 and bottomed with a low of 12.96.

Trading the stock market can sometimes feel like a wild roller coaster ride. When stocks are soaring, investors may feel like they can’t lose. When markets are sinking, investors may feel like there is nothing that they can do. Individual investors may have experienced both ends of the spectrum. Sometimes, an investor may secure some winning trades right out of the gate. This may cause the individual to become overconfident in their ability. Markets have the ability to shoot down overconfidence very quickly. On the other side, investors may only experience losses right off the bat and become highly discouraged. Figuring out how to manage winners and losers can big a big help to the investor’s psyche in the long-term. Frequently assessing which trades worked and examining why they worked may greatly assist the investor. The same can be said for trades that did not pan out.